CHEMCON
Chemcon Speciality Chemicals financials
- Market cap
- ₹796 Cr
- Sector
- Chemicals
What Chemcon Speciality Chemicals Limited does
Chemcon Speciality Chemicals manufactures organic chemicals (HMDS, CMIC, Bromobenzene, 2-Bromo) and inorganic bromides (Calcium Bromide, Zinc Bromide, Sodium Bromide) used as pharmaceutical intermediates, agrochemical/aromatic inputs and oilwell completion fluids. It is the only Indian manufacturer of HMDS and Zinc Bromide, the largest manufacturer of CMIC worldwide, and the largest manufacturer of Calcium Bromide in India. The company sells through both domestic and export channels, with exports (inclusive of deemed exports) reaching key markets such as the US, Japan, UAE, Italy, South Korea, Germany, China, Russia, Spain, Thailand and Malaysia. It also recently acquired Shivam Petrochem Industries via slump sale to add bulk drug intermediates such as Trityl Chloride, PTSCL, 2-CTC and TosMIC to its portfolio.
Segments
- Organic Chemicals
- Inorganic Chemicals
- Manufacturing plants
- 9 operational plants (Manjusar, Vadodara, Gujarat)
- Installed capacity - Organic Chemicals
- 11,400 MTPA (HMDS, CMIC, Bromobenzene, 2-Bromo and other ancillary products)
- Installed capacity - Inorganic Chemicals (Bromides)
- 15,000 MTPA
- Owned warehouses
- 6
- Proposed expansion units
- 2 (P-10, P-11) under process
- Employees
- 237 permanent employees (as of Mar 31, 2025)
Quarterly results
Q1 FY27: revenue up 22.2%, net profit up 83.3% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 53 | 54 | 55 | 54 | 54 +2% | 57 +6% | 75 +36% | 66 +22% |
| EBITDA | 9 | 11 | 6 | 8 | 7 −22% | 7 −36% | 9 +50% | 15 +88% |
| Net profit | 6 | 9 | 4 | 6 | 6 +0% | 5 −44% | 6 +50% | 11 +83% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −13.0% 1Y
1Y: ₹249.59 on 10 Sept 2025 → ₹217.23. High ₹283.29 (25 Sept 2025), low ₹125.92 (30 Mar 2026).
Financials, as filed
Revenue fell 7.5% a year over 3 years, FY23 to FY26. Operating margin narrowed to 12.9%.
| Year ending | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹303 Cr | ₹267 Cr | ₹208 Cr | ₹240 Cr |
| Operating profit | ₹71 Cr | ₹26 Cr | ₹33 Cr | ₹31 Cr |
| Operating margin | 23.3% | 9.7% | 15.9% | 12.9% |
| Interest | ₹1 Cr | ₹4 Cr | ₹4 Cr | ₹2 Cr |
| Depreciation | ₹8 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
| Net profit | ₹55 Cr | ₹19 Cr | ₹24 Cr | ₹23 Cr |
| Net margin | 18.2% | 7.1% | 11.5% | 9.6% |
| Cash from operations | ₹13 Cr | ₹12 Cr | ₹38 Cr | ₹42 Cr |
| Free cash flow | ₹-32 Cr | ₹-31 Cr | ₹29 Cr | ₹32 Cr |
| ROCE | 15.0% | 6.0% | 7.0% | 6.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹37 Cr | ₹37 Cr | ₹37 Cr | ₹37 Cr | ₹37 Cr | ₹37 Cr |
| Reserves | ₹317 Cr | ₹381 Cr | ₹421 Cr | ₹440 Cr | ₹476 Cr | ₹447 Cr |
| Borrowings | ₹6 Cr | ₹36 Cr | ₹64 Cr | ₹43 Cr | ₹0 Cr | ₹53 Cr |
| Other liabilities | ₹44 Cr | ₹45 Cr | ₹32 Cr | ₹26 Cr | ₹35 Cr | ₹32 Cr |
| Total liabilities | ₹404 Cr | ₹498 Cr | ₹553 Cr | ₹545 Cr | ₹548 Cr | ₹568 Cr |
| Fixed assets | ₹67 Cr | ₹82 Cr | ₹141 Cr | ₹146 Cr | ₹144 Cr | ₹195 Cr |
| Capital work in progress | ₹9 Cr | ₹34 Cr | ₹14 Cr | ₹42 Cr | ₹47 Cr | ₹21 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹11 Cr | ₹10 Cr |
| Other assets | ₹328 Cr | ₹382 Cr | ₹398 Cr | ₹356 Cr | ₹346 Cr | ₹342 Cr |
| Total assets | ₹404 Cr | ₹498 Cr | ₹553 Cr | ₹545 Cr | ₹548 Cr | ₹568 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
The ownership split has held steady since Jun 2025. The shareholder count shrank 7% to 64,587.
- Promoters
- 74.5%
- FIIs
- 0.3%
- Public
- 25.3%
Since Jun 2025
- FIIs −0.05 pp
- Public +0.04 pp
- Promoters 0.00 pp
How it drifted, 12 quarters
Ownership split by quarter, oldest first. Sep '23: Promoters 74.5%, FIIs 0.0%, DIIs 0.3%, Public 25.2%.Dec '23: Promoters 74.5%, FIIs 0.1%, DIIs 0.3%, Public 25.2%.Mar '24: Promoters 74.5%, FIIs 0.3%, DIIs 0.3%, Public 25.0%.Jun '24: Promoters 74.5%, FIIs 0.3%, DIIs 0.3%, Public 25.0%.Sep '24: Promoters 74.5%, FIIs 0.3%, DIIs 0.3%, Public 25.0%.Dec '24: Promoters 74.5%, FIIs 0.3%, DIIs 0.3%, Public 25.0%.Mar '25: Promoters 74.5%, FIIs 0.3%, DIIs 0.3%, Public 24.9%.Jun '25: Promoters 74.5%, FIIs 0.3%, Public 25.2%.Sep '25: Promoters 74.5%, FIIs 0.3%, Public 25.3%.Dec '25: Promoters 74.5%, FIIs 0.3%, Public 25.2%.Mar '26: Promoters 74.5%, FIIs 0.4%, Public 25.1%.Jun '26: Promoters 74.5%, FIIs 0.3%, Public 25.3%.
Who is on the register
Named in the Jun 2026 filing
Every holder of Chemcon Speciality Chemicals Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Kamalkumar Rajendra Aggarwal | 27.81% | unchanged |
| Naresh Goyal | 25.30% | unchanged |
| Rajveer Kamal Aggarwal | 6.91% | unchanged |
| Navdeep Naresh Goyal | 6.48% | unchanged |
| Shubharangana Naresh Goyal | 5.40% | unchanged |
| Minal Kamal Aggarwal | 2.54% | unchanged |
| Parul Uttsav Gupta | 0.01% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
What the price assumes
Growth trapTo justify its price of ₹217, this stock must grow earnings at 26% every year for 7 years. Our analysis caps realistic growth at ~-25%. At that growth it is worth ₹15 — downside of 93%.
- Growth the price implies
- 25.5% a year
- for 7 years, fading to 4%
- It has actually compounded at
- -25.3% a year
- net profit, FY23–FY26 · EPS -24.6%
- The gap
- 0.5 pp
- -93% downside if it only repeats history
Learn to analyse Chemcon Speciality Chemicals Limited
Guides on how to read this kind of business and the numbers that matter.